Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fruehauf

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Expert Opinion on Biological Therapy|December 4, 2003
Prospects and RISC score of viral gene therapy for sarcomaS Fruehauf, M R Veldwijk, W J Zeller, et al.
Acta Haematologica|January 1, 1993
Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapyS Fruehauf, C Fiehn, R Haas, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 6, 2003
Transfer of drug resistance genes in hematopoietic progenitors for chemoprotection: is it still an option?S Laufs, E C Buss, W J Zeller, et al.
British Journal of Cancer|May 3, 2002
Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioningJ Topaly, S Fruehauf, A D Ho, et al.
Journal of Leukocyte Biology|February 28, 2002
Functional characterization of podia formation in normal and malignant hematopoietic cellsS Fruehauf, K Srbic, R Seggewiss, et al.
Stem Cells (Dayton, Ohio)|August 26, 1998
Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapyS Fruehauf, M R Veldwijk, A Krämer, et al.
Bone Marrow Transplantation|November 1, 1994
Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesisR Möhle, M Pförsich, S Fruehauf, et al.
Gene Therapy|April 22, 2003
Rapid detection of retroviral vector integration sites in colony-forming human peripheral blood progenitor cells using PCR with arbitrary primersB Gentner, S Laufs, K Z Nagy, et al.
Cancer Gene Therapy|August 11, 2001
The FBMD-1 stroma cell line secretes a unique moiety which can increase retroviral transduction of lineage-committed and primitive human peripheral blood progenitor cellsE C Buss, B Schiedlmeier, A D Ho, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocksM R Veldwijk, B Schiedlmeier, J A Kleinschmidt, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Expert Opinion on Biological Therapy|December 4, 2003
Prospects and RISC score of viral gene therapy for sarcomaS Fruehauf, M R Veldwijk, W J Zeller, et al.
Acta Haematologica|January 1, 1993
Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapyS Fruehauf, C Fiehn, R Haas, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 6, 2003
Transfer of drug resistance genes in hematopoietic progenitors for chemoprotection: is it still an option?S Laufs, E C Buss, W J Zeller, et al.
British Journal of Cancer|May 3, 2002
Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioningJ Topaly, S Fruehauf, A D Ho, et al.
Journal of Leukocyte Biology|February 28, 2002
Functional characterization of podia formation in normal and malignant hematopoietic cellsS Fruehauf, K Srbic, R Seggewiss, et al.
Stem Cells (Dayton, Ohio)|August 26, 1998
Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapyS Fruehauf, M R Veldwijk, A Krämer, et al.
Bone Marrow Transplantation|November 1, 1994
Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesisR Möhle, M Pförsich, S Fruehauf, et al.
Gene Therapy|April 22, 2003
Rapid detection of retroviral vector integration sites in colony-forming human peripheral blood progenitor cells using PCR with arbitrary primersB Gentner, S Laufs, K Z Nagy, et al.
Cancer Gene Therapy|August 11, 2001
The FBMD-1 stroma cell line secretes a unique moiety which can increase retroviral transduction of lineage-committed and primitive human peripheral blood progenitor cellsE C Buss, B Schiedlmeier, A D Ho, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocksM R Veldwijk, B Schiedlmeier, J A Kleinschmidt, et al.
Pageof 6